IRWD · Ironwood Pharmaceuticals Inc
$4.31
+0.23 (+5.64%)
At close · Aug 14
Market Cap
$712.18M
Shares
165.24M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Ronald Silver | interim chief financial officer and principal financial officer | Appointed | 2026-05-13 |
| Gregory Martini | Senior Vice President, Chief Financial Officer | Resigned | 2026-05-13 |
| Andrew Dreyfus | Board of Directors | Resigned | 2025-10-10 |
| Gregory Martini | Senior Vice President, Chief Financial Officer | Appointed | 2025-01-29 |
| Sravan K. Emany | Senior Vice President, Chief Operating Officer and Chief Financial Officer | Resigned | 2024-12-05 |
| Andrew Davis | Senior Vice President, Chief Business Officer | Resigned | 2024-11-12 |
| Sravan K. Emany | Senior Vice President, Chief Operating Officer and Chief Financial Officer | Appointed | 2024-06-20 |
Key facts
CIK
1446847
CUSIP
46333X108
13F (30d)
208 filings
201 filers
Visit website
Investor relations